Third Point highlights SK Hynix’s HBM leadership, rising revenue mix, and deep valuation discount. Explore why this AI memory ...

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the ...

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of ...

Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient populationEncouraging safety and ...

Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma Two abstracts ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

The November 3 edition of the SBJ Facilities newsletter looks at how Intuit Dome is coaxing fans back to their seats during halftime and other pauses in the action in its second year, what executives ...

Q3 2025 Earnings Call November 3, 2025 8:30 AM ESTCompany ParticipantsJohn Kasel - President, CEO & DirectorWilliam Thalman ...

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

A medspa playbook to turn attention into bookings—clear pages, local SEO, and one-screen scheduling. Start booking more clients today!

Title: A dose-escalation and safety study of CID-103 followed by a randomized, open-label, parallel-arm multi-dose study ...